Multimode MALDI-MSI deciphers matrine-induced metabolic reprogramming in prostate cancer xenografts: spatial mapping of low-molecular-weight compound alterations.

Front Pharmacol · 2025 · PMC12756179 · PMID 41487492

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep = 0.05actually significant

However, this difference did not reach statistical significance ( p = 0.05), potentially due to sample heterogeneity or the partial nature of matrine’s anti-proliferative effects.

also in 58,632 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.